Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VTP-300 with or without nivolumab in chronic hepatitis B
NCT04778904Phase 2Completed
- Sponsor
- Barinthus Biotherapeutics
- Start
- Dec 2020
- Primary completion
- Feb 2023
- Modality
- Prophylactic Vaccines, Viral Vectors, DNA Vaccines
- Countries
- 3
01
Overview
A Phase 2 trial of ChAdOx1-HBV, MVA-HBV in Chronic Hepatitis B (CHB), sponsored by Barinthus Biotherapeutics. Started Dec 2020; status: completed.
02
Drugs
ChAdOx1-HBVMVA-HBV
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT04778904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04778904.